You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 11, 2025

Drugs Containing Excipient (Inactive Ingredient) DIBASIC CALCIUM PHOSPHATE DIHYDRATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE excipient

Dibasic Calcium Phosphate Dihydrate: Market Dynamics and Financial Trajectory

Introduction to Dibasic Calcium Phosphate Dihydrate

Dibasic calcium phosphate dihydrate, commonly known as dicalcium phosphate (DCP), is a synthetic salt with the chemical formula CaHPO4. It is a crucial component in various industries, including pharmaceuticals, animal feed, and fertilizers. Here, we will delve into the market dynamics and financial trajectory of DCP, particularly focusing on its role as a pharmaceutical excipient.

Market Size and Growth Projections

The global dicalcium phosphate market is valued at US$ 950 million in 2023 and is forecasted to reach US$ 1.2 billion by the end of 2033, growing at a CAGR of 2.1% over the next ten years[1].

Role in the Pharmaceutical Industry

Use as an Excipient

Dicalcium phosphate is widely used in the pharmaceutical industry as an excipient, particularly in tablet formulations. Its role includes acting as a filler, binder, and disintegrant, enhancing the stability and efficacy of pharmaceutical products. The expanding pharmaceutical sector, driven by increasing health awareness and a growing population, is a significant driver for the demand of DCP as an excipient[3].

Technological Advancements

Technological advancements in manufacturing processes have improved the quality and efficiency of DCP production. These advancements enable the production of high-quality DCP at lower costs, making it more competitive in the pharmaceutical market. Manufacturers investing in research and development are introducing innovative products and production processes, further driving market growth[3].

Market Drivers

Increasing Demand for Pharmaceuticals

The rising demand for pharmaceuticals, particularly in regions with growing populations and increasing health awareness, is a key driver for the DCP market. As the pharmaceutical industry expands, the demand for DCP as an excipient is expected to increase, presenting opportunities for market players to strengthen their presence in this segment[3].

Growing Health Awareness

Increasing health awareness among consumers is driving the demand for dietary supplements and other health-related products. Dicalcium phosphate, being a dietary supplement in the pharmaceutical industry, benefits from this trend. The growing geriatric population, for instance, is expected to increase the demand for food supplements, including those containing DCP[4].

Regional Market Dynamics

Asia Pacific Dominance

The Asia Pacific region is expected to maintain its position as the leading market for DCP. Countries like China and India are driving this growth due to the increasing demand for animal protein, natural feed additives, and fertilizers. Government initiatives supporting the agricultural sector in these countries also contribute to the market growth[1].

North American Market

In North America, particularly in the United States, the market for DCP is driven by a rising population, increasing dietary product demand, and growing health-related awareness. Technological advancements in production processes have led to higher quality and more efficient production of DCP, further supporting market growth in this region[1].

Market Restraints and Opportunities

Growing Demand for Organic Alternatives

The increasing emphasis on organic and sustainable farming practices presents a challenge for traditional DCP manufacturers. However, this also offers an opportunity for companies to develop organic and eco-friendly DCP formulations to cater to the growing demand for organic feed additives[3].

Fluctuating Raw Material Prices

The prices of raw materials such as calcium carbonate and phosphoric acid, which are used in the production of DCP, can fluctuate. These fluctuations can affect the profitability of manufacturers and impact the overall market dynamics. However, companies that can manage these fluctuations effectively can maintain a competitive edge[3].

Impact of COVID-19

The COVID-19 pandemic had a significant impact on the DCP market, both in the short and long term. While there were initial disruptions in supply chains and production, the pandemic also accelerated the demand for health-related products, including pharmaceuticals and dietary supplements containing DCP. This has contributed to the overall growth trajectory of the market[3].

Financial Trajectory

Revenue Generation

The DCP market offers lucrative opportunities for industry participants to generate substantial revenue. As the demand for animal feed additives, pharmaceuticals, and nutritional supplements continues to rise, companies can capitalize on this trend and expand their market share. The projected growth from US$ 950 million in 2023 to US$ 1.2 billion by 2033 indicates a stable financial trajectory for the market[1].

Key Market Insights

  • The pharmaceutical industry is a key consumer of DCP due to its use in tablet formulations.
  • Technological advancements and product innovations are driving market growth.
  • The Asia Pacific region is expected to dominate the market due to the presence of a large livestock population and rising disposable income[3].

Key Takeaways

  • The global dicalcium phosphate market is expected to grow at a CAGR of 2.1% from 2023 to 2033.
  • The pharmaceutical industry's expansion is a significant driver for the demand of DCP as an excipient.
  • Technological advancements and product innovations are crucial for market growth.
  • The Asia Pacific region, particularly China and India, will continue to dominate the market.
  • The market faces challenges from the growing demand for organic alternatives but also presents opportunities for innovation.

FAQs

Q: What is the primary use of dicalcium phosphate in the pharmaceutical industry?

A: Dicalcium phosphate is primarily used as an excipient in tablet formulations, acting as a filler, binder, and disintegrant.

Q: Which region is expected to dominate the dicalcium phosphate market?

A: The Asia Pacific region, particularly China and India, is expected to dominate the market due to the large livestock population and rising disposable income.

Q: How does the growing health awareness impact the dicalcium phosphate market?

A: Growing health awareness drives the demand for dietary supplements and pharmaceutical products, which in turn increases the demand for DCP as an excipient.

Q: What are the key drivers for the dicalcium phosphate market?

A: Key drivers include increasing demand for animal feed additives, growing health awareness, technological advancements, and the expanding pharmaceutical industry.

Q: How has the COVID-19 pandemic affected the dicalcium phosphate market?

A: The pandemic initially disrupted supply chains but also accelerated the demand for health-related products, contributing to the overall growth trajectory of the market.

Sources:

  1. FactMR, Dicalcium Phosphate Market Size, Demand & Growth Report 2023
  2. PoliFar Feed Additive, DCP 18% Feed Grade Dicalcium Phosphate for Livestock and Poultry Feed Supplement
  3. MarkWide Research, Dicalcium Phosphate market 2024-2032 | Size, Share, Growth
  4. Coherent Market Insights, Anhydrous Dibasic Calcium Phosphate Market Size & Share Analysis

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.